COSMOS Pharmaceutical (3349) · InitiativeConfirmation of full-year adoption
Application of Accounting Standards for Corporate Income Taxes
First written in FY2025-H1. . Latest entry: FY2025.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Adoption of the Accounting Standard for Income TaxesA theme 953 companies write about · 0 as a headwind · 1 as a tailwind
1 other company's latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 962 threads.Full recordFilings, disclosures and news, newest first
- FY2025Confirmation of full-year adoptionAnnual report
「We have applied the "Accounting Standard for Accounting for Income Taxes, Inhabitant Taxes and Enterprise Taxes" (Accounting Standards Board of Japan Statement No. 27, dated 28 October 2022; hereinafter, the "2022 Revised Accounting Standard") and other standards from the beginning of the current consolidated fiscal year.」
The Company states that it applied the accounting standards revised in 2022 and other related standards from the beginning of the current consolidated fiscal year, with no impact on the consolidated financial statements from the change in accounting policy. - FY2025-H1First statedAnnual report
「We have applied the Accounting Standard for Accounting for Income Taxes (Accounting Standard No. 27, 28 October 2022) and related standards from the beginning of the interim consolidated accounting period.」
The company adopted the revised 2022 accounting standards from the beginning of the interim consolidated accounting period and stated that the change had no impact on the interim consolidated financial statements.